Emma Reeve, Director at PTC THERAPEUTICS, INC. (PTCT), sold 8,556 shares at $55.04 ($471K) on 2023-04-21, disclosed to the SEC on 2023-04-25.
Scheduled sale ($471k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.04 | 4,228 | $233K | 49.4% |
| 2 | $55.04 | 4,228 | $233K | 49.4% |
| 3 | $55.57 | 100 | $6K | 1.2% |
| Total | $55.05 avg | 8,556 | $471K | 100% |
| Filing → |
| PTCT | SELL | 2025-11-25 | $795K | — | Filing → |
| PTCT | SELL | 2025-11-14 | $1.1M | — | Filing → |
| PTCT | SELL | 2025-10-31 | $1.1M | — | Filing → |